Secondary autoimmune and inflammatory diseases (sec.AIID) post allogeneic HSCT Diseases Group Transplant Complications Working Party (TCWP) Autoimmune Diseases Working Party (ADWP) Principal investigator Arsene Mekinian
Incidence and outcome of CMV and EBV reactivations after autologous HSCT for autoimmune diseases: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT) Group Autoimmune Diseases Working Party (ADWP) Type of Stem Cell Treatment Principal investigator Tobias Alexander
Comparison of Cyclophosphamide/ATG vs BEAM/ATG conditioning regimens in autologous HSCT for Multiple Sclerosis Group Autoimmune Diseases Working Party (ADWP) Principal investigator Riccardo Saccardi
Observational Study in Multiple Sclerosis patients treated with autologous hematopoietic stem cell Transplantation (OMST) Group Autoimmune Diseases Working Party (ADWP) Principal investigator Riccardo Saccardi
Outcomes of HSCT for autoimmune cytopenias (AIC): a Retrospective Registry Study from the Autoimmune Diseases Working Party (ADWP) and the Paediatric Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) Group Autoimmune Diseases Working Party (ADWP) Paediatric Diseases Working Party (PDWP) Type of Stem Cell Treatment Principal investigator Nichola Cooper
LATE COMPLICATIONS AFTER AUTOLOGOUS HSCT FOR AUTOIMMUNE DISEASES: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP) of the European Society for Blood and Marrow Transplantation (EBMT) Diseases Group Autoimmune Diseases Working Party (ADWP) Transplant Complications Working Party (TCWP) Paediatric Diseases Working Party (PDWP) Principal investigator Kirill Kirgizov
Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional approach across Europe (NISSC-2) Diseases Group Autoimmune Diseases Working Party (ADWP) Principal investigator Pr Dominique Farge
High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intravenous pulse therapy cyclophosphamide in severe systemic sclerosis Group Autoimmune Diseases Working Party (ADWP) Type of Stem Cell Treatment Principal investigator J.M. van Laar
Autologous Stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study across Europe Group Autoimmune Diseases Working Party (ADWP) Type of Stem Cell Treatment Principal investigator Ina Koetter
ASTIMS: High dose immunoablation and autologous haematopoietic stem cell transplantation versus mitoxantrone therapy in severe multiple sclerosis Group Autoimmune Diseases Working Party (ADWP) Type of Stem Cell Treatment Principal investigator G.L. Mancardi
Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Paediatric Multiple Sclerosis Group Autoimmune Diseases Working Party (ADWP) Paediatric Diseases Working Party (PDWP) Type of Stem Cell Treatment Principal investigator J Burman, K Kirgizov
Autologous Stem Cell Transplantation International Crohn's Disease Trial: a multicentre, prospective, randomised phase II study conducted by the European Crohn's and Colitis Organisation (ECCO), sponsored by the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation Group Autoimmune Diseases Working Party (ADWP) Type of Stem Cell Treatment Principal investigator Christopher J Hawkey